


Factory Sells Best Quality ARA290 (Cibinetide) 1208243-50-8 with USP We provide high quality Poziotinib (CAS 1208243-50-8), at a very affordable prices to our customers.
Poziotinib is a small molecule inhibitor of the pan-HER family of receptors, including EGFR, HER2, and HER4. It is a promising pharmaceutical candidate for the treatment of various solid tumors, particularly non-small cell lung cancer. Poziotinib functions by blocking the activity of these receptors, which are associated with cell proliferation, survival, and resistance to targeted therapies. Its ability to effectively inhibit tumor growth and improve patient outcomes has been demonstrated in clinical trials, making it a potentially valuable option for cancer treatment. However, further research is needed to fully understand its safety and efficacy profile.
Used in Oncology:
Poziotinib is used as an anticancer agent for the treatment of various solid tumors, especially non-small cell lung cancer. It works by inhibiting the activity of the pan-HER family of receptors, which play a crucial role in cell proliferation, survival, and resistance to targeted therapies. This inhibition helps in effectively controlling tumor growth and improving patient outcomes.
Used in Drug Resistance:
Poziotinib is used to overcome resistance to targeted therapies in cancer treatment. By blocking the activity of the pan-HER family of receptors, it can help in reducing the resistance to other targeted therapies, making them more effective in treating cancer.
Used in Clinical Trials:
Poziotinib is used in clinical trials to evaluate its safety, efficacy, and potential as a cancer treatment. These trials help in understanding its impact on tumor growth, patient outcomes, and its overall profile in the context of cancer treatment.
The CAS number of Poziotinib is 1208243-50-8.
More information of Poziotinib 1208243-50-8 are:
|
CAS Number |
1208243-50-8 |
The chemical formula of Poziotinib is which containing , and the molecular weight of Poziotinib is 0
Poziotinib is a small molecule inhibitor of the pan-HER family of receptors, including EGFR, HER2, and HER4. It is a promising pharmaceutical candidate for the treatment of various solid tumors, particularly non-small cell lung cancer. Poziotinib functions by blocking the activity of these receptors, which are associated with cell proliferation, survival, and resistance to targeted therapies. Its ability to effectively inhibit tumor growth and improve patient outcomes has been demonstrated in clinical trials, making it a potentially valuable option for cancer treatment. However, further research is needed to fully understand its safety and efficacy profile.
Relevant articles related to Poziotinib:
HUAJING INDUSTRIAL LIMITED is a quality supplier of Poziotinib. Our main goal is customer satisfaction. Contact us to negotiate the best price for your business on Poziotinib 1208243-50-8.